Topical corticosteroid reforms adjuvant capecitabine chemotherapy. (T-CRACC STUDY)

ABSTRACT: Interventions: Administration of hydrocortisone topical;Medication Primary outcome(s): Frequency of occurrence of grade 2 or higher hand foot syndrome at the end of adjuvant chemotherapy (3 months after the start of adjuvant chemotherapy) Study Design: single arm study, open(masking not used), uncontrolled control, single assignment, prevention purpose

DISEASE(S): Colorectal Cancer

PROVIDER: 2728863 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR